Research News
View articles by month and year
31–37 of 37 articles
-
Women’s Health Initiative Study Suggests Women Who Took Combination Hormone Replacement Therapy Have Higher Risk of Breast Cancer
Results from the Women's Health Initiative show that women who took combination hormone replacement therapy (HRT) were more likely to be diagnosed with breast and lung cancer after they quit taking the HRT than women who got a placebo.
-
Detecting Breast Cancer More Difficult in Women Taking Hormone Replacement Therapy
Taking combination HRT (hormone replacement therapy) makes it more likely that a woman will have an abnormal mammogram and can make routine screening mammograms harder to read.
-
Using Hormone Replacement Therapy for as Few as 3 Years Increases Risk
Using combination hormone replacement therapy for 3 years or more can increase the risk of lobular breast cancer.
-
Drop in Breast Cancer Diagnoses Comes with Drop in Hormone Replacement Therapy Use
Another study links hormone replacement therapy (HRT) and increased breast cancer risk.
-
Breast Cancer After Combination Hormone Replacement Therapy Use Less Aggressive
Breast cancer diagnosed after combination HRT tends to have a better prognosis than cancer diagnosed after estrogen-only HRT.
-
Using Estrogen-Only Hormone Replacement Therapy for 5 Years or More Ups Risk
A Finnish study shows that taking estrogen-only hormone replacement therapy may slightly increase breast cancer risk.
-
Drop in Breast Cancer Rates Linked to Drop in Hormone Replacement Therapy Use
A sharp decline in new breast cancer cases in 2003 in the United States have come because millions of older women ceased hormone replacement therapy the previous year.
31–37 of 37 articles
